Markets / IPO / Corona Remedies

Corona Remedies IPO

Updated 23:11

Mainboard IPO on NSE and BSE · Pharmaceuticals

Status
Listed
Price band
₹1,008–1,062
Lot size
14 shares · ₹14,868
Subscribed
137.04×

How it listed

Issue price
₹1,062
Listing price (open)
₹1,470.00 +38.42%
First-day close
₹1,438.40 +35.44%
Price now
₹2,441.10 +129.86%
Listing day15 Dec 2025
Open / high / low / close₹1,470.00 / ₹1,497.80 / ₹1,413.00 / ₹1,438.40
Shares traded on NSE1,28,89,175
Market value at the listing-day close₹8,797 cr

Closing prices since listing: 26 Oct ₹2,041.40, 27 Oct ₹2,152.00, 28 Oct ₹2,200.60, 29 Oct ₹2,217.40, 30 Oct ₹2,149.60, 2 Nov ₹2,171.10, 3 Nov ₹2,271.60, 4 Nov ₹2,405.80, 5 Nov ₹2,379.80, 6 Nov ₹2,441.10.

Corona Remedies share price, live chart and technicals →

Key dates

Bidding opens8 Dec 2025
Bidding closes10 Dec 2025
Allotment11 Dec 2025
Refunds and shares in demat12 Dec 2025
Listing15 Dec 2025

Issue reservation

Investor groupShares% of issueMost applicants allotted
Institutions (QIB)12,88,73228.19%–
HNI / NII9,66,54921.14%–
  HNI, above ₹10 lakh6,44,36614.09%676
  HNI, ₹2–10 lakh3,22,1837.05%1,643
Retail22,55,28149.33%1,61,091
Employees61,3201.34%–

Shares NSE lists as offered to each group, plus the anchor portion. "Most applicants allotted" is how many people can get the minimum application in that group when it is oversubscribed.

Lot size by investor type

ApplicationLotsSharesAmount
Retail (minimum)114₹14,868
Retail (maximum)13182₹1,93,284
Small HNI (minimum)14196₹2,08,152
Small HNI (maximum)67938₹9,96,156
Big HNI (minimum)68952₹10,11,024

At ₹1,062 a share. Retail bids go up to ₹2 lakh, small HNI from ₹2 lakh to ₹10 lakh, big HNI above ₹10 lakh.

Chance of getting shares (retail)

Chance
At least 1 in 29
Retail allotments available
1,61,091 × one lot
Retail portion subscribed
28.73×

An estimate from the times the retail portion was subscribed, as if every applicant bid for the minimum. Many bid for more lots, so the real chance is usually better. Winners are picked by lottery and each gets the minimum (one lot).

Subscription

Investor categoryShares offeredShares bid forTimes subscribed
Institutions (QIB)12,88,73235,89,39,448278.52×
HNI / NII9,66,54920,18,97,066208.88×
  HNI, above ₹10 lakh6,44,36615,07,93,356234.02×
  HNI, ₹2–10 lakh3,22,1835,11,03,710158.62×
Retail22,55,2816,48,02,03828.73×
Employees61,3209,02,88814.72×
Total45,71,88262,65,41,440137.04×

NSE and BSE bids together, as of 10 Dec 2025 19:00.

Demand at each price

Top price ₹1,0625,720.16 lakh shares91.3%
Cut-off final price, whatever it is; mostly retail544.77 lakh shares8.7%
Lower prices ₹1,008–1,0612.32 lakh shares0.0%

Shares bid on NSE and BSE at each price in the band. Most bids at the top price, and little at lower prices, means buyers were keen.

Anchor investors

Anchor bid date5 Dec 2025
Lock-in ends for the first 50% (30 days)9 Jan 2026
Lock-in ends for the remaining 50% (90 days)10 Mar 2026

Anchor investors are large funds that buy the day before the IPO opens. SEBI locks in half their shares for 30 days from the allotment and the rest for 90 days; they can sell from the next trading day. Traders watch these dates because extra selling can come in.

Financials and valuation

At issue priceNow
Market value₹6,495 cr₹14,930 cr
P/E (last 12 months' profit)31.472.1
Revenue, last 12 months₹1,559 cr
Profit, last 12 months₹207 cr
Return on equity25.7%
Debt to equity0.12

From results the company filed with NSE (latest period to 30 Sept 2026). Twelve-month figures need four quarters of results, so they fill in over the first year after listing.

Other recent IPOs: Pharmaceuticals

CompanyListedSubscribedOn listingSince IPO
Symbiotec Pharmalab 1 Sept71.26×0.00%+53.20%
Bio Medica Laboratories SME29 May–-20.00%+4.57%
Sai Parenteral's 2 Apr1.05×+2.04%+18.97%
KRM Ayurveda SME29 Jan–+27.48%+68.89%
Curis Lifesciences SME14 Nov–+14.14%+38.36%
Rubicon Research 16 Oct103.90×+27.84%+242.12%
Amanta Healthcare 9 Sept82.61×+7.14%+54.98%
Anlon Healthcare 3 Sept7.13×-89.89%-70.33%

IPO details

Price band₹1,008–1,062
Final issue price₹1,062
Lot size14 shares
Minimum investment₹14,868 (1 lot)
MarketNSE mainboard
Issue type100% Book Building
Face value₹10 per Equity Share
IndustryPharmaceuticals
Issue size₹655.37 crore (about 61.71 lakh shares) · Offer for sale only
ISININE02ZQ01018
RegistrarBigshare Services Private Limited
Helpline: +91 22626 38200, ipo@bigshareonline.com
Lead managersJM Financial Limited, IIFL Capital Services Limited and Kotak Mahindra Capital Company Limited
ProspectusRed herring prospectus (NSE)

Check allotment status

Allotment was finalised on 11 Dec 2025. Check it on the registrar's page (Bigshare Services Private Limited), NSE or BSE with your PAN or application number.

← All IPOs: open, upcoming and recently listed

From NSE's official IPO data. Expected dates follow SEBI's T+3 timetable; the exchange confirms them. Information only, not investment advice.

What is the Corona Remedies IPO price band and lot size?

The price band is ₹1,008–1,062 per share, and one lot is 14 shares (₹14,868 at the upper price).

When is the Corona Remedies IPO allotment date?

Allotment was finalised on 11 Dec 2025, the next working day after bidding closed on 10 Dec 2025.

How many times was the Corona Remedies IPO subscribed?

In total 137.04 times, on NSE and BSE together; retail 28.73 times.

What is the Corona Remedies IPO listing date?

It listed on 15 Dec 2025 on NSE and BSE.

What is the chance of getting Corona Remedies IPO shares?

At least 1 in 29 retail applicants got the minimum lot: 1,61,091 retail allotments with the retail portion subscribed 28.73 times. Winners are picked by lottery.

When does the Corona Remedies anchor lock-in end?

The 30-day lock-in on half of the anchor investors' shares ends on 9 Jan 2026 and the 90-day lock-in on the rest ends on 10 Mar 2026; they can sell from the next trading day.

What was the Corona Remedies listing gain?

It opened at ₹1,470.00 against an issue price of ₹1,062, a gain of 38.42%. It is now up 129.86% from the issue price.